NewGenIvf Group Ltd is a SG-based company operating in Health Care Providers & Services industry. The company employs 76 full-time employees The company went IPO on 2022-02-15. NewGenIvf Group Limited is a comprehensive fertility services provider in Asia, helping couples and individuals obtain access to fertility treatments. The firm offers services, such as Mitochondrial Replacement Therapy (MRT) In Reproductive, Intrauterine Insemination (IUI), MRT techniques, In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), semen analysis, testicular/epididymal sperm aspiration or extraction/percutaneous epididymal sperm aspiration, embryo transfer, chromosome screening, and egg freezing. The Company’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. The Company’s subsidiary is NewGenIvf Limited.
Follow-Up Questions
NewGenIvf Group Ltd의 CEO는 누구입니까?
Mr. Claudius Tsang은 2021부터 회사에 합류한 NewGenIvf Group Ltd의 Chairman of the Board입니다.
NIVF 주식의 가격 성능은 어떻습니까?
NIVF의 현재 가격은 $0.6385이며, 전 거래일에 increased 0.7% 하였습니다.
NewGenIvf Group Ltd의 주요 사업 주제나 업종은 무엇입니까?
NewGenIvf Group Ltd은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
